Mariner LLC Sells 25,062 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Mariner LLC decreased its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 23.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 81,856 shares of the company's stock after selling 25,062 shares during the period. Mariner LLC owned approximately 0.07% of Privia Health Group worth $1,600,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Barclays PLC grew its position in Privia Health Group by 240.3% in the third quarter. Barclays PLC now owns 224,018 shares of the company's stock valued at $4,079,000 after acquiring an additional 158,188 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of Privia Health Group in the 3rd quarter valued at approximately $263,000. Franklin Resources Inc. grew its holdings in shares of Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock valued at $23,092,000 after purchasing an additional 28,480 shares during the last quarter. JPMorgan Chase & Co. increased its position in Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company's stock worth $3,430,000 after purchasing an additional 14,641 shares in the last quarter. Finally, Nordea Investment Management AB lifted its stake in Privia Health Group by 33.1% in the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company's stock valued at $6,953,000 after purchasing an additional 86,910 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.

Insider Transactions at Privia Health Group

In related news, CFO David Mountcastle sold 5,630 shares of the business's stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the sale, the chief financial officer now directly owns 179,676 shares of the company's stock, valued at $4,021,148.88. The trade was a 3.04 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 10.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on PRVA. Needham & Company LLC reaffirmed a "buy" rating and set a $30.00 target price on shares of Privia Health Group in a research note on Thursday, April 10th. Truist Financial boosted their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. Barclays increased their target price on Privia Health Group from $21.00 to $23.00 and gave the company an "equal weight" rating in a research report on Thursday, April 10th. Robert W. Baird boosted their price target on Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a report on Tuesday, April 15th. Finally, Stephens reiterated an "overweight" rating and issued a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. One investment analyst has rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $27.14.

Privia Health Group Stock Up 0.3 %

PRVA stock opened at $23.46 on Friday. The firm has a market cap of $2.85 billion, a price-to-earnings ratio of 234.62, a PEG ratio of 3.47 and a beta of 0.88. The company's fifty day simple moving average is $23.68 and its 200 day simple moving average is $21.82. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $26.04.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.